Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hemlibra
Biotech
Novo Nordisk's Hemlibra rival hits goals in phase 3
A phase 3 trial of a challenger to the blockbuster hemophilia drug hit its primary endpoint, clearing the path for a filing for approval this year.
Nick Paul Taylor
May 14, 2024 9:16am
Novo Nordisk hemophilia hopeful can't shake Pfizer's shadow
Jun 27, 2023 4:00pm
Novo's attempt to snatch Roche's hemophilia crown gets serious
Jul 12, 2022 9:21am
Sanofi preps hemophilia duo for patients seeking normalcy
Jul 10, 2022 9:45am
Sanofi hits goal in hemophilia A and plots race to regulators
Mar 9, 2022 7:15am
